Skip to content
Medical Health Aged Care

RACGP welcomes deferral of changes to chronic disease funding

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) welcomes the Federal Government acting on its calls to delay reform to chronic disease management funding for general practice, so Australians don’t face higher out-of-pocket costs. 

Changes to funding for Chronic Disease Management (CDM) Medicare items were set to be introduced on 1 November and have been delayed to 1 July 2025. 

RACGP President Dr Nicole Higgins said: “I’m pleased the Government has listened to GPs and deferred the changes to chronic disease management funding in general practice. 

“Australia has an epidemic of chronic illness. More than half of the population is living with one of more chronic condition, and it’s a leading cause of disability and premature death. Access to affordable healthcare is critical for these patients. 

"A recent newsGP poll of our members shows 69% of 1,367 respondents said they would be unable to bulk bill chronic disease patients, if current funding for chronic disease management is cut.  

“There is no substitute for the quality care you get from a GP who knows you, and your history, particularly when it comes to chronic disease management. It’s what helps patients live healthier and longer lives and stay out of hospital. 

“I look forward to working with the Government to ensure that there is enough funding for Australian’s living with chronic illness to get the care they need from their GP.” 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992[email protected]

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.